HbA1c, decoded.

The editorial TLDR.

What HbA1c actually is.

Hemoglobin is the iron-containing protein inside red blood cells that carries oxygen from the lungs to the rest of the body. When glucose levels in the bloodstream are higher, some of that glucose attaches non-enzymatically to hemoglobin molecules — a slow, irreversible chemical reaction called glycation. Once a hemoglobin molecule has been glycated, it stays that way for the life of the red blood cell, which is roughly 120 days.

At any given moment, your bloodstream contains red cells of all ages — newly minted ones, three-week-old ones, three-month-old ones. The percentage of total hemoglobin that's been glycated reflects the average glucose exposure across that whole population of cells. Higher running glucose means more glycation; lower running glucose means less. The number doesn't capture the spikes — a single high meal won't move it — but it captures the average, which is what matters most for the slow-burn damage of chronically elevated blood sugar.

"Fasting glucose tells you about one morning. HbA1c tells you about three months — the same window your tissues have been living in."

HbA1c became a standard diagnostic in U.S. medicine after large studies — DCCT and UKPDS — demonstrated that lowering HbA1c reduced microvascular and cardiovascular complications in people with diabetes. It was formalized as a diagnostic criterion for diabetes by the American Diabetes Association in 2010, joining fasting glucose and the oral glucose tolerance test.

One technical wrinkle worth knowing: HbA1c is influenced by anything that changes the lifespan or composition of red blood cells. Iron deficiency anemia, recent blood loss, pregnancy, hemoglobinopathies (sickle cell trait, thalassemia traits) and certain kidney conditions can all shift the number up or down independently of actual glucose status. This is one reason HbA1c is generally read alongside other glucose markers — fasting glucose, fructosamine, or continuous glucose monitoring data — when the picture seems off.

Why HbA1c matters for women.

Several women-specific patterns make HbA1c worth a thoughtful read rather than a glance-and-move-on.

PCOS and insulin resistance. Polycystic ovary syndrome affects roughly 8–13% of U.S. women of reproductive age, and insulin resistance is one of its defining features. Women with PCOS are at substantially elevated lifetime risk for type 2 diabetes — multiple guidelines now recommend periodic HbA1c (and sometimes a 2-hour oral glucose tolerance test) starting in the late twenties or thirties, well before standard screening guidelines would otherwise begin. An HbA1c in the high-5% range, paired with PCOS, is the kind of finding that informs prevention conversations a decade before a diagnosis would otherwise land.

Gestational diabetes history. Women who develop gestational diabetes have roughly a 7-fold higher lifetime risk of developing type 2 diabetes. Current U.S. guidance recommends HbA1c or fasting glucose testing within the first year after a gestational diabetes pregnancy, and then every 1–3 years thereafter. This is one of the cleaner examples of a pregnancy-related finding that should fundamentally change long-term cardiometabolic screening.

Pregnancy and gestational diabetes. Pregnancy itself shifts HbA1c interpretation. Many obstetricians don't use HbA1c as the primary gestational diabetes screen — most U.S. obstetric practice uses an oral glucose challenge test (the 50-gram, then 75-gram or 100-gram protocol) between weeks 24 and 28 of pregnancy. HbA1c is most useful in pregnancy for women with pre-existing diabetes or for assessing risk before conception, since blood sugar control in the weeks before and around conception meaningfully affects pregnancy outcomes.

Perimenopause and menopause. The hormonal shifts of perimenopause affect glucose regulation. Many women see their HbA1c drift upward through their late forties and fifties — sometimes from middling-low 5% to upper 5% — without obvious lifestyle changes. Estrogen decline contributes to insulin resistance, central weight redistribution shifts metabolic patterns, and sleep disruption (common in perimenopause) directly affects glucose handling. HbA1c is one of the cleaner markers to track through this window.

Cycle and hormonal patterns. Day-to-day glucose readings can vary across the menstrual cycle — many women run slightly higher glucose in the luteal phase (the second half of the cycle) than the follicular phase. HbA1c, because it averages over months, smooths past this variation. But the cycle effect on a single fasting glucose can be enough to push a borderline reading from one side of a threshold to the other, which is one reason HbA1c is often a more stable read than a single glucose draw in pre-menopausal women.

Iron deficiency considerations. Women, particularly those with heavy menstrual bleeding, are more likely to be iron-deficient than men. Iron deficiency tends to raise HbA1c readings independently of actual glucose status — by changing red-cell turnover. Conversely, iron repletion or recent blood loss can lower the reading. In women with known iron issues, the HbA1c picture is best read alongside ferritin and a CBC.

The "too late" pattern. Type 2 diabetes is the leading cause of new blindness, kidney failure, and non-traumatic amputation in U.S. adults, and the patterns that lead to it typically build over a decade before diagnosis. The conventional U.S. screening approach often catches diabetes in the 6.5%+ range, after years of upward drift through the prediabetes band. Earlier and more frequent HbA1c in women with PCOS, gestational diabetes history, or family history of type 2 diabetes is one of the more concrete examples of prevention being clearly better than diagnosis.

What the ranges generally mean.

Most U.S. labs report HbA1c as a percentage. The American Diabetes Association bands are widely used clinically across the country.

Illustrative educational bands, not diagnostic thresholds in isolation. Diagnosis generally requires confirmation with a second reading or additional glucose testing. HbA1c can be affected by iron deficiency, pregnancy, recent blood loss and hemoglobin variants. Always discuss your specific result with a qualified healthcare provider.

What may drive HbA1c low or high.

The patterns below come up most often when HbA1c sits outside the comfortable zone — particularly in U.S. women.

What may drive HbA1c elevated.

• Insulin resistance and PCOS. By far the most common driver in midlife women. Often shows up first as upper-5% HbA1c well before fasting glucose drifts.
• Visceral adiposity and metabolic syndrome. Central abdominal weight is metabolically active and directly affects insulin sensitivity.
• Family history of type 2 diabetes. A first-degree relative with diabetes substantially raises lifetime risk. Worth earlier and more frequent screening.
• Previous gestational diabetes. Roughly 7-fold higher lifetime risk of type 2 diabetes. Postpartum HbA1c testing is standard.
• Perimenopause and menopause. Hormonal shifts and sleep disruption contribute to gradual upward drift in glucose handling.
• Ultra-processed diet patterns. Diets high in refined carbohydrates, sugar-sweetened beverages and ultra-processed foods are associated with higher HbA1c.
• Sedentary patterns. Physical activity directly affects insulin sensitivity. Even modest, regular movement makes a measurable difference.
• Chronic stress and poor sleep. Both affect cortisol and insulin signalling. Often underestimated.
• Iron deficiency anemia. Tends to falsely elevate HbA1c by altering red-cell turnover. Worth checking ferritin alongside.
• Certain medications. Long-term corticosteroids, some antipsychotics, certain blood pressure medications can raise glucose. Worth a medication review.
• Pregnancy (third trimester). Naturally rising glucose patterns. HbA1c interpretation in pregnancy is different from non-pregnancy.

What may drive HbA1c lower than expected.

• Generally healthy metabolic state. The most common reason for a comfortably low reading is the absence of the drivers listed above.
• Regular physical activity. Particularly strength training and post-meal walking. Both improve glucose handling.
• Lower-glycemic-load diet patterns. Mediterranean-style eating, balanced macronutrients and reduced refined-carbohydrate intake all tend to lower HbA1c.
• Recent blood loss or anemia recovery. Shorter red-cell lifespan can lower HbA1c readings independently of actual glucose status. Heavy menstrual bleeding is one source.
• Pregnancy first half. Many women see HbA1c drop modestly in the first half of pregnancy due to increased red-cell turnover.
• Hemoglobinopathies. Sickle cell trait, thalassemia traits and other variants can produce misleadingly low (or high) readings on standard assays. Worth a fructosamine or CGM alternative if suspected.
• Effective diabetes management. The single most common medical reason for an HbA1c that's lower than it used to be.

Your provider will guide the conversation based on your full medical context. These prompts are designed to make sure HbA1c gets read alongside the rest of the metabolic picture.

When to test, and how it's measured.

HbA1c is a standard venous blood draw. Unlike fasting glucose, it does not require fasting — one of its main practical advantages. Most U.S. labs run it as a standalone test or alongside a comprehensive metabolic panel. Results typically return within a few business days.

Pairing makes the picture richer. A meaningful metabolic workup for U.S. women often includes HbA1c, fasting glucose, fasting insulin, lipid panel (with ApoB), and hsCRP. The combination catches both the average-glucose story (HbA1c), the early insulin-resistance story (fasting insulin), and the related cardiovascular and inflammatory context (ApoB, hsCRP). Single-marker workups miss patterns the full set surfaces.

Cycle day doesn't materially affect HbA1c because it averages over months. Iron status, pregnancy and recent blood loss can affect it, as discussed above. Hemoglobin variants (sickle cell trait, thalassemia trait) can produce misleading readings; if these are known or suspected, alternative markers — fructosamine, glycated albumin, or continuous glucose monitoring (CGM) data — can be useful.

Continuous glucose monitoring (CGM) is increasingly available without prescription in the U.S. for non-diabetic adults curious about their metabolic patterns. CGM gives 14-day glucose tracings rather than a 3-month average — different information, complementary rather than competing with HbA1c. Worth a conversation if you're working through a metabolic picture and want to see how individual foods, sleep nights or workouts affect your numbers.

Direct-to-consumer at-home tests — Function Health, LetsGetChecked, Quest Direct and others — include HbA1c in their broader cardiometabolic panels. They're useful for a baseline; they don't replace the conversation about what to do with the result. See our guide to at-home blood tests for women for a fuller comparison.

Related biomarkers worth understanding.

HbA1c rarely sits alone in a thoughtful metabolic workup. The markers below come up most often alongside it.

• Fasting insulin and HOMA-IR — insulin resistance often shows up here years before HbA1c moves. Particularly valuable in women with PCOS or family history of type 2 diabetes. A dedicated Heme guide to fasting insulin is in development.
• Fasting glucose — one morning's value. Read together with HbA1c for a more honest picture.
• ApoB — atherogenic particle count. Often rises alongside HbA1c in cardiometabolic patterns.
• hsCRP — inflammation. Frequently elevated alongside HbA1c in insulin-resistant patterns.
• Ferritin — iron status can affect HbA1c readings. Worth a baseline check alongside.
• TSH — thyroid. Hypothyroidism can affect glucose handling. Worth ruling in or out alongside metabolic markers.